Cdn Warrant News

Megalith Financial Acquisition Corp Class A Commo (NYSE:MFAC) Shorts Rose By 0.11% – Z Tribune

Megalith Financial Acquisition Corp Class A Commo (NYSE:MFAC) Shorts Rose By 0.11% Z Tribune Change of 0.11% for Megalith Financial Acquisition Corp Class A Commo (NYSE:MFAC)’s short interest was registered. It was announced in April by FINRA the. … Continue reading

Megalith Financial Acquisition Corp Class A Commo (NYSE:MFAC) Shorts Rose By 0.11% – Z Tribune Read More »

ATE.V: Phase 2b Efficacy Trial for ATB-346 Underway… – Zacks Small Cap Research

ATE.V: Phase 2b Efficacy Trial for ATB-346 Underway… Zacks Small Cap Research 04/02/2019. Download this Report (). By David Bautz, PhD. TSX:ATE.V READ THE FULL ATE.V RESEARCH REPORT Business Update Phase 2b Study of … … Continue reading

ATE.V: Phase 2b Efficacy Trial for ATB-346 Underway… – Zacks Small Cap Research Read More »

STRATA Skin Sciences Announces Preliminary Fourth Quarter and Full-Year 2018 Revenue Results – Nasdaq

STRATA Skin Sciences Announces Preliminary Fourth Quarter and Full-Year 2018 Revenue Results Nasdaq Unaudited Fourth Quarter 2018 total revenue was $8.1 million, with recurring revenue of $6.0 million, representing a 10.7% increase in installed base utilization. … Continue reading

STRATA Skin Sciences Announces Preliminary Fourth Quarter and Full-Year 2018 Revenue Results – Nasdaq Read More »

Stockwatch: A 50% rebound warrants investigation – Analysis & Commentary – Interactive Investor

Stockwatch: A 50% rebound warrants investigation – Analysis & Commentary Interactive Investor After bouncing strongly off a four-year low, should investors keep buying this mid-cap share, or sell the rally? I’m interested to re-examine £420 million AIM-listed … … Continue reading

Stockwatch: A 50% rebound warrants investigation – Analysis & Commentary – Interactive Investor Read More »

Altimmune Announces Financial Results for the Year Ended December 31, 2018 and Provides Corporate Update – Nasdaq

Altimmune Announces Financial Results for the Year Ended December 31, 2018 and Provides Corporate Update Nasdaq GAITHERSBURG, Md., April 01, 2019– Altimmune, Inc., a clinical-stage immunotherapeutics company, today announced financial results for the year. … Continue reading

Altimmune Announces Financial Results for the Year Ended December 31, 2018 and Provides Corporate Update – Nasdaq Read More »

Dawson James Securities Announces the Closing of Public Offering for Precision Therapeutics Inc. – GlobeNewswire

Dawson James Securities Announces the Closing of Public Offering for Precision Therapeutics Inc. GlobeNewswire BOCA RATON, Fla., April 01, 2019 (GLOBE NEWSWIRE) — Dawson James Securities Inc. in conjunction with Precision Therapeutics Inc. (NASDAQ: AIPT) … … Continue reading

Dawson James Securities Announces the Closing of Public Offering for Precision Therapeutics Inc. – GlobeNewswire Read More »

Flower One Announces Full Exercise of Over-Allotment Option Resulting in a Public Offering for Gross Proceeds of $57.5 Million – Canada NewsWire

Flower One Announces Full Exercise of Over-Allotment Option Resulting in a Public Offering for Gross Proceeds of $57.5 Million Canada NewsWire NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./ TORONTO, April 1, 2019 /CNW/ … … Continue reading

Flower One Announces Full Exercise of Over-Allotment Option Resulting in a Public Offering for Gross Proceeds of $57.5 Million – Canada NewsWire Read More »

Citius Pharmaceuticals (CTXR) Announces $5.3 Million Registered Direct Offering of Common Stock Priced At-the-Market – StreetInsider.com

Citius Pharmaceuticals (CTXR) Announces $5.3 Million Registered Direct Offering of Common Stock Priced At-the-Market StreetInsider.com Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Citius Pharmaceuticals Inc. (Nasdaq: CTXR), … … Continue reading

Citius Pharmaceuticals (CTXR) Announces $5.3 Million Registered Direct Offering of Common Stock Priced At-the-Market – StreetInsider.com Read More »

Somerset Capital Management Llp Cut Its Copa Holdings (CPA) Stake by $1.47 Million; Pinnacle Holdings Stake in Wintrust Financial (WTFC) Has Decreased by $44.55 Million as Shares Declined – D Minute

Somerset Capital Management Llp Cut Its Copa Holdings (CPA) Stake by $1.47 Million; Pinnacle Holdings Stake in Wintrust Financial (WTFC) Has Decreased by $44.55 Million as Shares Declined D Minute Somerset Capital Management Llp decreased its stake in Copa Holdings (CPA) by 57.45% based on its latest 2018Q4 regulatory filing with the SEC. Somerset … … Continue reading

Somerset Capital Management Llp Cut Its Copa Holdings (CPA) Stake by $1.47 Million; Pinnacle Holdings Stake in Wintrust Financial (WTFC) Has Decreased by $44.55 Million as Shares Declined – D Minute Read More »